Select Page

SARS-CoV-1 and MERS-CoV Research Tools

GeneCopoeia provides OmicsLink™ Expression-Ready ORF cDNA clones, lentiviral particles and AAV particles that express the viral proteins from SARS-CoV-1 and MERS-CoV, the human pathogenic coronaviruses that caused the 2002 SARS and 2012 MERS disease outbreaks, respectively. Each ORF can be cloned into one of our more than 250 vector types, which can be selected from the drop-down menus below.

For more information or to request a quote, please contact inquiry@genecopoeia.com

 

SARS-CoV-1 ORF cDNA plasmid clones-viral proteins

SARS-CoV-1 is the coronavirus that caused the Severe Acute Respiratory Syndrome (SARS) epidemic that began in Guangdong, China in 2002 and ended in 2004.

To order ORF clones expressing SARS-CoV-1 proteins, click on the product ID corresponding to the viral protein of interest in the table below.

Product ID Accession Symbol Aliases Description
SV01_01 NP_828860.1 orf1ab sars1 leader protein
SV01_02 NP_828861.1 orf1ab sars1 counterpart of MHV p65

SV01_03

(please inquire)

NP_828862.1 orf1ab sars1 nsp3-pp1a/pp1ab
SV01_04 NP_828863.1 orf1ab sars1 3C-like proteinase
SV01_05 NP_828864.1 orf1ab sars1 nsp6-pp1a/pp1ab (TM3)
SV01_06 NP_828865.1 orf1ab sars1 nsp7-pp1a/pp1ab
SV01_07 NP_828866.1 orf1ab sars1 nsp8-pp1a/pp1ab
SV01_08 NP_828867.1 orf1ab sars1 ssRNA-binding protein
SV01_09 NP_828868.1 orf1ab sars1 formerly known as growth-factor-like protein(GFL)
SV01_10 NP_828869.1 orf1ab sars1 RNA-dependent RNA polymerase
SV01_11 NP_828870.1 orf1ab sars1 nsp13-pp1ab (ZD, NTPase/HEL; RNA 5'-triphosphatase)
SV01_12 NP_828871.1 orf1ab sars1 3'-to-5' exonuclease
SV01_13 NP_828872.1 orf1ab sars1 uridylate-specific endoribonuclease NendoU
SV01_14 NP_828873.1 orf1ab sars1 2'-O-ribose methyltransferase (2'-o-MT)
SV03_01 NP_828851.1 S sars2 E2 glycoprotein precursor
SV04_01 NP_828852.1   sars3a hypothetical protein sars3a
SV05_01 NP_828853.1   sars3b hypothetical protein sars3b
SV06_01 NP_828854.1 E sars4 protein E
SV07_01 NP_828855.1 M sars5 matrix protein
SV08_01 NP_828856.1   sars6 hypothetical protein sars6
SV09_01 NP_828857.1   sars7a hypothetical protein sars7a
SV10_01 NP_828858.1 N sars9a nucleocapsid protein
SV11_01 NP_828859.1   sars9b hypothetical protein sars9b

 

MERS-CoV plasmid clones-viral proteins

MERS-CoV is the coronavirus that caused Middle East Respiratory Syndrome (MERS), that began in Saudi Arabia in September 2012. As of September 2020, this outbreak is still ongoing.

To order ORF clones expressing MERS-CoV proteins, click on the product ID corresponding to the viral protein of interest in the table below.

Product ID Accession Symbol Aliases Description

MV01

(please inquire)

YP_009047202.1 orf1ab G128_gp01 1ab polyprotein [Middle East respiratory syndrome-related coronavirus], full-length gene
MV02 YP_009047213.1 orf1ab G128_gp01 nsp1 protein [Middle East respiratory syndrome-related coronavirus], mature peptide

MV03

(please inquire)

YP_009047214.1 orf1ab G128_gp01 nsp2 protein [Middle East respiratory syndrome-related coronavirus], mature peptide*
MV04 YP_009047215.1 orf1ab G128_gp01 nsp3 protein [Middle East respiratory syndrome-related coronavirus], mature peptide*
MV05 YP_009047216.1 orf1ab G128_gp01 nsp4 protein [Middle East respiratory syndrome-related coronavirus], mature peptide*
MV06 YP_009047217.1 orf1ab G128_gp01 nsp5 protein [Middle East respiratory syndrome-related coronavirus], mature peptide*
MV07 YP_009047218.1 orf1ab G128_gp01 nsp6 protein [Middle East respiratory syndrome-related coronavirus], mature peptide*
MV08 YP_009047219.1 orf1ab G128_gp01 nsp7 protein [Middle East respiratory syndrome-related coronavirus], mature peptide*
MV09 YP_009047220.1 orf1ab G128_gp01 nsp8 protein [Middle East respiratory syndrome-related coronavirus], mature peptide*
MV10 YP_009047221.1 orf1ab G128_gp01 nsp9 protein [Middle East respiratory syndrome-related coronavirus], mature peptide*
MV11 YP_009047222.1 orf1ab G128_gp01 nsp10 protein [Middle East respiratory syndrome-related coronavirus], mature peptide*
MV12 YP_009047223.1 orf1ab G128_gp01 nsp12 protein [Middle East respiratory syndrome-related coronavirus], mature peptide*
MV13 YP_009047224.1 orf1ab G128_gp01 nsp13 protein [Middle East respiratory syndrome-related coronavirus], mature peptide*
MV14 YP_009047225.1 orf1ab G128_gp01 nsp14 protein [Middle East respiratory syndrome-related coronavirus], mature peptide*
MV15 YP_009047226.1 orf1ab G128_gp01 nsp15 protein [Middle East respiratory syndrome-related coronavirus], mature peptide*
MV16 YP_009047227.1 orf1ab G128_gp01 nsp16 protein [Middle East respiratory syndrome-related coronavirus], mature peptide*
MV17 YP_009047203.1 orf1ab G128_gp01 1A polyprotein [Middle East respiratory syndrome-related coronavirus], full-length gene
MV18 YP_009047228.1 orf1ab G128_gp01 nsp11 protein [Middle East respiratory syndrome-related coronavirus], mature peptide*
MV19 YP_009047204.1 S G128_gp02 spike glycoprotein [Middle East respiratory syndrome-related coronavirus], full-length gene
MV20 YP_009047205.1 orf3 G128_gp03 NS3 protein [Middle East respiratory syndrome-related coronavirus], full-length gene
MV21 YP_009047206.1 orf4a G128_gp04 NS4A protein [Middle East respiratory syndrome-related coronavirus], full-length gene
MV22 YP_009047207.1 orf4b G128_gp05 NS4B protein [Middle East respiratory syndrome-related coronavirus], full-length gene
MV23 YP_009047208.1 orf5 G128_gp06 NS5 protein [Middle East respiratory syndrome-related coronavirus], full-length gene
MV24 YP_009047209.1 E G128_gp07 envelope protein [Middle East respiratory syndrome-related coronavirus], full-length gene
MV25 YP_009047210.1 M G128_gp08 membrane protein [Middle East respiratory syndrome-related coronavirus], full-length gene
MV26 YP_009047211.1 N G128_gp09 nucleoprotein [Middle East respiratory syndrome-related coronavirus], full-length gene
MV27 YP_009047212.1 orf8b G128_gp10 ORF8b protein [Middle East respiratory syndrome-related coronavirus], full-length gene

*Note: Mature peptides are produced as a result of proteolytic processing of larger precursor proteins. To enable expression of these proteins in cells, an ATG has been added to the 5' end of the ORF sequence.

 

 

COVID-19 Coronavirus Antigen Microarray

SARS-CoV-2 is a betacoronavirus that is the cause of the COVID-19 global pandemic that began in 2019. SARS-CoV-2 infection of humans typically stimulates a strong humoral immunity response, leading to the production of both neutralizing and binding antibodies.

GeneCopoeia provides COVID-19-related antigen microarrays for two purposes: 1) Association of autoimmunity against cytokines with SARS-CoV-2 infection (Coronavirus Associated Autoimunity microarray, catalog # PA012); and 2) Detection of antibodies against SARS-CoV-2 (including variants of concern) and other pathogens (SARS-CoV-2 Coronavirus Variant Proteins microarray, catalog # PA013).

In addition to these predesigned arrays, arrays containing customized sets of proteins are available, as well as array profiling services and data analysis.

GeneCopoeia’s OmicsArray™ SARS-CoV-2 Coronavirus Antigen Microarrays are part of the GeneCopoeia OmicsArray™ Antigen Microarray family.

 
Advantages
  • Multiplexing capable.  OmicsArray™ antigen microarrays can assay up to 120 antigens at a time, compared with 1 protein at a time for ELISA.
  • High throughput.  Each slide can process up to 15 samples in parallel.
  • High sensitivity.  Each array can detect as little as 1 pg/ml of antibody, which is 100-fold more sensitive than ELISA.
  • Small sample volume.  As little as 1 ul of serum is needed for detection.
  • Fast.  From sample-to-data in as little as 2 weeks.
Predesigned arrays Premade antigen microarrays GeneCopoeia’s OmicsArray™ COVID-19 Coronavirus Antigen Microarrays are premade protein microarrays. Please refer to the table below for more information.
Catalog number Number of Antigens Description
PA012 120 Human Coronavirus-associated Autoimmunity (CAA)
PA013 58 NEW! SARS-CoV-2 coronavirus variant proteins
 

User Manual

Custom protein microarrays are also available. To inquire about a custom protein microarray, please contact inquiry@genecopoeia.

AdenoFect™ Adenovirus

GeneCopoeia’s Adenovirus products are the ideal tools for expressing or modifying genes for in vitro and in vivo research. Adenovirus is a popular choice for gene delivery applications primarily because of its large packaging capacity, high transgene expression, and ability to infect most cell types; it is also widely used in cardiovascular, liver, muscle, lung, tumor, stem cell and other fields. Once inside the cell, recombinant adenovirus remains episomal and does not integrate into the host genome.

Advantages
  • High titers.  Titer of recombinant adenovirus particles can be up to 1012 VP/ml.
  • Versatile.  Usable in a broad range of host cell and animals.
  • Large packaging capacity.  The packaging capacity of recombinant adenovirus can be up to 5 kb.
  • High transduction efficiency.
  • Low toxicity.  Does not integrate into the host genome.
  • Safe.  Recombinant adenovirus is replication-incompetent (El (early protein) and/or E3 deletion mutants).
Search all recombinant adenovirus products by gene ID or accession number

Figure 1. Hela, A549, and Vero cells in 12-well plates were transduced with the indicated amounts of eGFP ultra-purified AdenoFect™ Adenovirus particles (Cat#. AD05-EGFP-EB001, 3.39×1012vp/mL, 1.56 μl/well) at MOI 10. The expression of eGFP was visualized with a fluorescence microscope at 15, 24, and 48 hours post-transduction respectively.

 

Custom Adenovirus

Custom Adenovirus

Custom adenovirus production services are available for human, mouse and rat ORF cDNAs. For custom adenovirus packaging service, please contact us at inquiry@genecopoeia.com to get a quote.

Choose from our collection of adenovirus vectors with different promoters and fluorescent markers for your gene expression.

Adenovirus Vector List

Vector name Promoter Promoter description Reporter gene
pAdv-EB001 CMV Strong promoter, broad scope of application. N/A
pAdv-EB002 CAG Ubiquitous. Better choice than CMV for in vivo applications. N/A
pAdv-EB003 EF-1α Broad scope of application. Better choice than CMV for in vivo applications. N/A
pAdv-EB007 CMV Strong promoter, broad scope of application. IRES-eGFP
pAdv-EB008 CAG Ubiquitous. Better choice than CMV for in vivo applications. IRES-eGFP
pAdv-EB009 EF-1α Broad scope of application. Better choice than CMV for in vivo applications. IRES-eGFP

 

 

(more…)